Trials / Completed
CompletedNCT04018885
A Study on Safety and Preliminary Efficacy of ALA in Acne Vulgaris
A Multi-center, Open, Randomized, Parallel Group Study to Assess Safety, Tolerance and Preliminary Efficacy of ALA for the Treatment of Moderate to Severe Acne Vulgaris
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to explore the safety, tolerability, and preliminary efficacy of ALA used with photodynamic therapy for the treatment of moderate to severe acne vulgaris.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ALA 2.5% | Topical treatment for photodynamic therapy, after drug incubation subsequent illumination with red light (72 J/cm2). 4 treatments at an interval of 10 (± 4) days. |
| DRUG | ALA 5% | Topical treatment for photodynamic therapy, after drug incubation subsequent illumination with red light (72 J/cm2). 4 treatments at an interval of 10 (± 4) days. |
| DRUG | ALA 10% | Topical treatment for photodynamic therapy, after drug incubation subsequent illumination with red light (72 J/cm2). 4 treatments at an interval of 10 (± 4) days. |
Timeline
- Start date
- 2019-07-11
- Primary completion
- 2020-01-20
- Completion
- 2020-01-20
- First posted
- 2019-07-15
- Last updated
- 2020-06-02
Locations
4 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04018885. Inclusion in this directory is not an endorsement.